Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lortz, S.
Right arrow Articles by Lenzen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lortz, S.
Right arrow Articles by Lenzen, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 49, Issue 7 1123-1130, Copyright © 2000 by American Diabetes Association


ARTICLES

Protection of insulin-producing RINm5F cells against cytokine-mediated toxicity through overexpression of antioxidant enzymes

S Lortz, M Tiedge, T Nachtwey, AE Karlsen, J Nerup and S Lenzen
Institute of Clinical Biochemistry, Hanover Medical School, Germany.

Nitric oxide (NO) and reactive oxygen species (ROS) are crucial elements in cytokine-mediated beta-cell destruction. In insulin-producing RINm5F cells, overexpression of cytoprotective enzymes provides significant protection against the synergistic toxicity of NO and ROS. We therefore examined whether overexpression of catalase (Cat), glutathione peroxidase (Gpx), and Cu/Zn superoxide dismutase (SOD) can provide protection for bioengineered RINm5F cells against cytokine-mediated toxicity. A 72-h exposure of RINm5F control cells to interleukin-1beta (IL-1beta) alone or a combination of IL-1beta, tumor necrosis factor-alpha, and gamma-interferon resulted in a time- and concentration-dependent decrease of cell viability in the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) cytotoxicity assay. Although IL-1beta alone caused only a moderate reduction of viability in the range of 25%, the cytokine mixture induced a significant loss of viability of >75%. This increased toxicity of the cytokine mixture compared with that of IL-1beta alone could be explained by a higher rate of NO generation within the early 24-48 h incubation period that would favor the toxic synergism of NO and oxygen free radicals. Overexpression of Cat, Gpx, and Cu/Zn SOD protected against toxicity of the cytokine mixture but not against that of IL-1beta alone. The reduction of cytokine-mediated toxicity was evident also because of an increased proliferation rate and a drastic decrease in the cell death rate. The improved antioxidant defense status did not prevent the activation of iNOS after cytokine exposure. However, RINm5F cells overexpressing cytoprotective enzymes showed a significantly lower level of ROS-damaged protein residues. Thus, protection through Cat, Gpx, and Cu/Zn SOD overexpression was apparently because of an inactivation of ROS generated in the signal cascades of the cytokines. Overexpression of cytoprotective enzymes thus represents a feasible strategy to protect insulin-producing cells against cytokine-mediated cytotoxicity.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al.
Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo
Diabetes, December 1, 2007; 56(12): 2927 - 2937.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T.-a. Matsuoka, H. Kaneto, R. Stein, T. Miyatsuka, D. Kawamori, E. Henderson, I. Kojima, M. Matsuhisa, M. Hori, and Y. Yamasaki
MafA Regulates Expression of Genes Important to Islet {beta}-Cell Function
Mol. Endocrinol., November 1, 2007; 21(11): 2764 - 2774.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. J. Zunino, D. H. Storms, and C. B. Stephensen
Diets Rich in Polyphenols and Vitamin A Inhibit the Development of Type I Autoimmune Diabetes in Nonobese Diabetic Mice
J. Nutr., May 1, 2007; 137(5): 1216 - 1221.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Li, H. Chen, and P. N. Epstein
Metallothionein and Catalase Sensitize to Diabetes in Nonobese Diabetic Mice: Reactive Oxygen Species May Have a Protective Role in Pancreatic {beta}-Cells
Diabetes, June 1, 2006; 55(6): 1592 - 1604.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
T. B. Mysore, T. A. Shinkel, J. Collins, E. J. Salvaris, N. Fisicaro, L. J. Murray-Segal, L. E.A. Johnson, D. A. Lepore, S. N. Walters, R. Stokes, et al.
Overexpression of Glutathione Peroxidase With Two Isoforms of Superoxide Dismutase Protects Mouse Islets From Oxidative Injury and Improves Islet Graft Function
Diabetes, July 1, 2005; 54(7): 2109 - 2116.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Chen, X. Li, and P. N. Epstein
MnSOD and Catalase Transgenes Demonstrate That Protection of Islets From Oxidative Stress Does Not Alter Cytokine Toxicity
Diabetes, May 1, 2005; 54(5): 1437 - 1446.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Matsuda, K. Ferreri, I. Todorov, Y. Kuroda, C. V. Smith, F. Kandeel, and Y. Mullen
Silymarin Protects Pancreatic {beta}-Cells against Cytokine-Mediated Toxicity: Implication of c-Jun NH2-Terminal Kinase and Janus Kinase/Signal Transducer and Activator of Transcription Pathways
Endocrinology, January 1, 2005; 146(1): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Aikin, D. Maysinger, and L. Rosenberg
Cross-Talk between Phosphatidylinositol 3-Kinase/AKT and c-Jun NH2-Terminal Kinase Mediates Survival of Isolated Human Islets
Endocrinology, October 1, 2004; 145(10): 4522 - 4531.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
E. Gurgul, S. Lortz, M. Tiedge, A. Jorns, and S. Lenzen
Mitochondrial Catalase Overexpression Protects Insulin-Producing Cells Against Toxicity of Reactive Oxygen Species and Proinflammatory Cytokines
Diabetes, September 1, 2004; 53(9): 2271 - 2280.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Li, H. Chen, and P. N. Epstein
Metallothionein Protects Islets from Hypoxia and Extends Islet Graft Survival by Scavenging Most Kinds of Reactive Oxygen Species
J. Biol. Chem., January 2, 2004; 279(1): 765 - 771.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Cao, Z. Gao, C. E. Robert, S. Greene, G. Xu, W. Xu, E. Bell, D. Campbell, Y. Zhu, R. Young, et al.
Pancreatic-Derived Factor (FAM3B), a Novel Islet Cytokine, Induces Apoptosis of Insulin-Secreting {beta}-Cells
Diabetes, September 1, 2003; 52(9): 2296 - 2303.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. P. Bindokas, A. Kuznetsov, S. Sreenan, K. S. Polonsky, M. W. Roe, and L. H. Philipson
Visualizing Superoxide Production in Normal and Diabetic Rat Islets of Langerhans
J. Biol. Chem., March 7, 2003; 278(11): 9796 - 9801.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. P. Robertson, J. Harmon, P. O. Tran, Y. Tanaka, and H. Takahashi
Glucose Toxicity in {beta}-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Diabetes, March 1, 2003; 52(3): 581 - 587.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. K. Azevedo-Martins, S. Lortz, S. Lenzen, R. Curi, D. L. Eizirik, and M. Tiedge
Improvement of the Mitochondrial Antioxidant Defense Status Prevents Cytokine-Induced Nuclear Factor-{kappa}B Activation in Insulin-Producing Cells
Diabetes, January 1, 2003; 52(1): 93 - 101.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Cnop, J. C. Hannaert, A. Y. Grupping, and D. G. Pipeleers
Low Density Lipoprotein Can Cause Death of Islet {beta}-Cells by Its Cellular Uptake and Oxidative Modification
Endocrinology, September 1, 2002; 143(9): 3449 - 3453.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Nakayama, M. Nagata, H. Yasuda, K. Arisawa, R. Kotani, K. Yamada, S. A. Chowdhury, S. Chakrabarty, Z. Z. Jin, H. Yagita, et al.
Fas/Fas Ligand Interactions Play an Essential Role in the Initiation of Murine Autoimmune Diabetes
Diabetes, May 1, 2002; 51(5): 1391 - 1397.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. D. Piganelli, S. C. Flores, C. Cruz, J. Koepp, I. Batinic-Haberle, J. Crapo, B. Day, R. Kachadourian, R. Young, B. Bradley, et al.
A Metalloporphyrin-Based Superoxide Dismutase Mimic Inhibits Adoptive Transfer of Autoimmune Diabetes by a Diabetogenic T-Cell Clone
Diabetes, February 1, 2002; 51(2): 347 - 355.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Johannesen, A. Pie, F. Pociot, O. P. Kristiansen, A. E. Karlsen, and J. Nerup
Linkage of the Human Inducible Nitric Oxide Synthase Gene to Type 1 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2792 - 2796.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. M. Larsen, S.J. Fey, M.R. Larsen, A. Nawrocki, H.U. Andersen, H. Kähler, C. Heilmann, M.C. Voss, P. Roepstorff, F. Pociot, et al.
Proteome Analysis of Interleukin-1{beta}-Induced Changes in Protein Expression in Rat Islets of Langerhans
Diabetes, May 1, 2001; 50(5): 1056 - 1063.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. E. Karlsen, S. G. Ronn, K. Lindberg, J. Johannesen, E. D. Galsgaard, F. Pociot, J. H. Nielsen, T. Mandrup-Poulsen, J. Nerup, and N. Billestrup
Suppressor of cytokine signaling 3 (SOCS-3) protects beta -cells against interleukin-1beta - and interferon-gamma -mediated toxicity
PNAS, October 9, 2001; 98(21): 12191 - 12196.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2000 by the American Diabetes Association.